7-Phenyl-2,5,7-triazaspiro[3.4]octane-6,8-dione hydrochloride, 95%, 250mg

3-Chloro-5-fluorobenzonitrile, 97.0%, 25g

3,4-Methylenedioxynitrobenzene>98.0%(GC)500g

3-Methyl-2-pentanol (mixture of diastereoisomers)>98.0%(GC)25mL

N-methyl-1-(5-methyl-1H-benzimidazol-2-yl)methanamine, 95.0%, 10g

2-(4-Bromophenyl)thiazolidine-4-carboxylic acid, 95%, 100g

2-(2-(TRITYLOXY)ETHOXY)ETHANOL, 95%, 25g

Récepteur à vide droit, 24/29, 24/29, 1 pièce

N'-[1-Amino-2-p-tolylethylidine]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 1g

Ethyl(1S,3S,4R)-4-bromo-3-hydroxycyclohexane-1-carboxylate, 98%, 500mg

tert-Butyl aziridine-1-carboxylate, 95.0%, 5g

2-(4-Chlorophenyl)-4,5-dihydro-1H-imidazole, 95%, 250mg

Methyl 2-(2-bromo-4-chlorophenyl)acetate, 95.0%, 10g